Amplification and overexpression of the cyclin D1 and epidermal growth factor receptor genes in non-small-cell lung cancer

[1]  A. Marchetti,et al.  Cyclin D1 and retinoblastoma susceptibility gene alterations in non‐small cell lung cancer , 1998, International journal of cancer.

[2]  M. Fukumoto,et al.  Cyclin‐D1‐gene amplification is a more potent prognostic factor than its protein over‐expression in human head‐and‐neck squamous‐cell carcinoma , 1997, International journal of cancer.

[3]  C. Sheehan,et al.  The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma , 1997, Cancer.

[4]  M. Buyse,et al.  Immunocytochemical markers in stage I lung cancer: relevance to prognosis. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  A. Hart,et al.  Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. , 1997, Archives of otolaryngology--head & neck surgery.

[6]  S. Gansauge,et al.  Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis. , 1997, Cancer research.

[7]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[8]  A. Ariza,et al.  CYCLIN D1 OVEREXPRESSION IN NON‐SMALL CELL LUNG CARCINOMA: CORRELATION WITH Ki67 LABELLING INDEX AND POOR CYTOPLASMIC DIFFERENTIATION , 1996, The Journal of pathology.

[9]  H. Kato,et al.  A comparison of epidermal growth factor receptor levels and other prognostic parameters in non-small cell lung cancer. , 1996, European journal of cancer.

[10]  C. Rose,et al.  Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections. , 1996, British Journal of Cancer.

[11]  W. Mooi,et al.  The prognostic value of NCAM, p53 and cyclin D1 in resected non-small cell lung cancer. , 1996, Lung cancer.

[12]  F. Bosch,et al.  Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity. , 1996, The American journal of pathology.

[13]  W. Ryder,et al.  Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. , 1996, British Journal of Cancer.

[14]  C. Albanese,et al.  Transforming p21ras Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions (*) , 1995, The Journal of Biological Chemistry.

[15]  N. Sonenberg,et al.  Eukaryotic Translation Initiation Factor 4E Regulates Expression of Cyclin D1 at Transcriptional and Post-transcriptional Levels (*) , 1995, The Journal of Biological Chemistry.

[16]  B. Angus,et al.  Determination of the prognostic value of cyclin D1 overexpression in breast cancer. , 1995, Oncogene.

[17]  S. Ng,et al.  Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells , 1995, Molecular and cellular biology.

[18]  M. Gaffey,et al.  Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis. , 1995, Archives of otolaryngology--head & neck surgery.

[19]  E. Dmitrovsky,et al.  Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development. , 1995, Cancer research.

[20]  C. D. Edwards,et al.  Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. , 1995, Cancer research.

[21]  E. Holmes.  Historic background of the Lung Cancer Study Group. , 1994, Chest.

[22]  F. Bosch,et al.  PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. , 1994, Cancer research.

[23]  R. Sclafani,et al.  Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  N. Nishida,et al.  Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. , 1994, Cancer research.

[25]  Jiri Bartek,et al.  Cyclin D1 protein expression and function in human breast cancer , 1994, International journal of cancer.

[26]  J. Bartek,et al.  Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. , 1994, Cancer research.

[27]  J. Bartek,et al.  Cell cycle‐related variation and tissue‐restricted expression of human cyclin D1 protein , 1994, The Journal of pathology.

[28]  C. Harris,et al.  Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Figlin,et al.  Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group. , 1993, Oncogene.

[30]  G. Gibson,et al.  The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival. , 1993, British Journal of Cancer.

[31]  Charles J. Sherr,et al.  Mammalian G1 cyclins , 1993, Cell.

[32]  E. Dmitrovsky,et al.  Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. , 1993, Cancer research.

[33]  M. Tsao,et al.  In vitro and in vivo expressions of transforming growth factor-alpha and tyrosine kinase receptors in human non-small-cell lung carcinomas. , 1993, The American journal of pathology.

[34]  M. J. van de Vijver,et al.  Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. , 1992, Cancer research.

[35]  I. Weinstein,et al.  Amplification and expression of the human cyclin D gene in esophageal cancer. , 1992, Cancer research.

[36]  G. Fuller,et al.  Amplified cellular oncogenes in neoplasms of the human central nervous system. , 1992, Mutation research.

[37]  E. Schuuring,et al.  Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. , 1992, Oncogene.

[38]  N. Hayward,et al.  Analysis of gene amplification in head‐and‐neck squamous‐cell carcinomas , 1991, International journal of cancer.

[39]  G E Moore,et al.  Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas. , 1991, Cancer research.

[40]  A. Arnold,et al.  A novel cyclin encoded by a bcl1-linked candidate oncogene , 1991, Nature.

[41]  T. Gilmer,et al.  Oncogene amplification in squamous cell carcinoma of the head and neck. , 1990, Archives of otolaryngology--head & neck surgery.

[42]  K. Somers,et al.  Amplification of the int-2 gene in human head and neck squamous cell carcinomas. , 1990, Oncogene.

[43]  M. Noguchi,et al.  Amplification of protooncogenes in surgical specimens of human lung carcinomas. , 1989, Cancer research.

[44]  G. Merlo,et al.  Expression of int-2 mRNA in human tumors amplified at the int-2 locus. , 1989, Oncogene.

[45]  J. Yang,et al.  Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas. , 1989, Oncogene.

[46]  I. Weinstein,et al.  Amplification of the EGF receptor and c‐myc genes in human esophageal cancers , 1988, International journal of cancer.

[47]  B. Vogelstein,et al.  Gene Amplification in Malignant Human Gliomas: Clinical and Histopathologic Aspects , 1988, Journal of neuropathology and experimental neurology.

[48]  G. Peters,et al.  Amplification of the int-2 gene in primary human breast tumors. , 1988, Oncogene research.

[49]  K. Kinzler,et al.  Relationship between gene amplification and chromosomal deviations in malignant human gliomas. , 1987, Cancer genetics and cytogenetics.

[50]  K. Kinzler,et al.  Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[51]  C. Mountain,et al.  A new international staging system for lung cancer. , 1987, Chest.

[52]  M. Berger,et al.  Epidermal growth factor receptors in lung tumours , 1987, The Journal of pathology.

[53]  A. Eisbruch,et al.  Analysis of the epidermal growth factor receptor gene in fresh human head and neck tumors. , 1987, Cancer research.

[54]  J. Farndon,et al.  EPIDERMAL-GROWTH-FACTOR RECEPTOR STATUS AS PREDICTOR OF EARLY RECURRENCE OF AND DEATH FROM BREAST CANCER , 1987, The Lancet.

[55]  J. B. Santon,et al.  Epidermal growth factor and its receptor , 1987, Molecular and Cellular Endocrinology.

[56]  G. Gibson,et al.  Epidermal growth factor receptors in non-small cell lung cancer. , 1987, British Journal of Cancer.

[57]  I. Damjanov,et al.  Immunohistochemical localization of the epidermal growth factor receptor in normal human tissues. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[58]  M. Melamed,et al.  Expression of epidermal growth factor receptor in human cultured cells and tissues: relationship to cell lineage and stage of differentiation. , 1986, Cancer research.

[59]  P. Hasleton,et al.  Expression of epidermal growth factor receptor (EGF-R) in human lung tumours. , 1986, British Journal of Cancer.

[60]  J. Cairncross,et al.  Amplified, overexpressed and rearranged epidermal growth factor receptor gene in a human astrocytoma cell line. , 1985, Biochemical and biophysical research communications.

[61]  Hermona Soreq,et al.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin , 1985, Nature.

[62]  B. Ozanne,et al.  Human squamous cell lung cancers express increased epidermal growth factor receptors. , 1984, The Journal of clinical investigation.

[63]  Y H Xu,et al.  Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells. , 1984, Science.

[64]  I. Todd,et al.  Bronchial Carcinoma , 1930, Edinburgh Medical Journal.

[65]  J A TAIANA,et al.  [Cancer of the lung]. , 1952, The Journal of the International College of Surgeons.

[66]  M. Furihata,et al.  Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma. , 1998, British Journal of Cancer.

[67]  M. Caputi,et al.  Prognostic role of cyclin D1 in non small cell lung cancer: an immunohistochemical analysis. , 1997, European journal of histochemistry : EJH.

[68]  P. Wingo,et al.  Cancer statistics, 1997 , 1997, CA: a cancer journal for clinicians.

[69]  I. Weinstein,et al.  Overexpression of cyclin D1 enhances gene amplification. , 1996, Cancer research.

[70]  C. Angeletti,et al.  Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype. , 1995, European journal of cancer.

[71]  G. Merlo,et al.  The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails the bcl-1, int-2 and hst loci. , 1989, Oncogene.

[72]  Atsushi Ochiai,et al.  Expression of epidermal growth factor receptor in human gastric and colonic carcinomas. , 1988, Cancer research.